ELDN profile · all as-reported value updates

Eledon Pharmaceuticals, Inc. (ELDN) as-reported value updates

Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.

Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.

Rows publish only when the later filed value differs by at least 1.0% and at least $1,000,000, after dropping differences that match under the capped trailing-zero precision rule. The delta percent is delta divided by the larger absolute filed value. Values are annual standardized facts only; metrics whose differences fall below those thresholds or match the capped precision rule are not published as rows.

Ledger table figure

Metric	FY	Earliest XBRL-filed value	Currently on file	Difference	Difference %	Label	Filing links	Notes
Stockholders' equity StockholdersEquity	2023	83,419,000 filed 2024-03-28 · 10-K	-48,486,000 filed 2026-03-19 · 10-K	-131,905,000	-158.12%	figure amended in 10-K/A	0000950170-24-038091 0001193125-26-116164	5 filed observations examined for this concept and period.
Stockholders' equity StockholdersEquity	2016	26,858,000 filed 2017-03-03 · 10-K	-2,702,000 filed 2019-03-28 · 10-K	-29,560,000	-110.06%	revised comparative figure	0001193125-17-069741 0001564590-19-009631	3 filed observations examined for this concept and period.
Assets Assets	2016	29,761,000 filed 2017-03-03 · 10-K	1,196,000 filed 2018-04-02 · 10-K	-28,565,000	-95.98%	revised comparative figure	0001193125-17-069741 0001564590-18-007314	2 filed observations examined for this concept and period.
Cash and cash equivalents CashAndCashEquivalentsAtCarryingValue	2016	23,223,000 filed 2017-03-03 · 10-K	1,103,000 filed 2018-04-02 · 10-K	-22,120,000	-95.25%	revised comparative figure	0001193125-17-069741 0001564590-18-007314	2 filed observations examined for this concept and period.
Liabilities Liabilities	2023	5,647,000 filed 2024-03-28 · 10-K	81,858,000 filed 2025-08-14 · 10-K/A	76,211,000	+93.10%	figure amended in 10-K/A	0000950170-24-038091 0001193125-25-180865	4 filed observations examined for this concept and period.
Net income NetIncomeLoss	2016	-37,959,000 filed 2017-03-03 · 10-K	-5,655,000 filed 2018-04-02 · 10-K	32,304,000	+85.10%	revised comparative figure	0001193125-17-069741 0001564590-18-007314	2 filed observations examined for this concept and period.
Stockholders' equity StockholdersEquity	2022	84,183,000 filed 2023-03-30 · 10-K	23,788,000 filed 2025-08-14 · 10-K/A	-60,395,000	-71.74%	figure amended in 10-K/A	0000950170-23-011011 0001193125-25-180865	5 filed observations examined for this concept and period.
Net income NetIncomeLoss	2023	-40,326,000 filed 2024-03-28 · 10-K	-116,537,000 filed 2025-08-14 · 10-K/A	-76,211,000	-65.40%	figure amended in 10-K/A	0000950170-24-038091 0001193125-25-180865	4 filed observations examined for this concept and period.
Stockholders' equity StockholdersEquity	2024	118,140,000 filed 2025-03-20 · 10-K	62,446,000 filed 2026-03-19 · 10-K	-55,694,000	-47.14%	figure amended in 10-K/A	0000950170-25-042754 0001193125-26-116164	3 filed observations examined for this concept and period.